Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

about

Sitagliptin and oral cancer risk in type 2 diabetes patients.Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis

P2860

Q47096984-DAE6EDA7-92DF-4A19-BA86-CBECF5BB62C8 Q50199885-324CDAC6-1D58-40AD-B79E-13B71A113E64 Q59127002-1975AA4A-E33E-4F83-8C41-3512BF2789F0

P2860

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

Item

http://www.wikidata.org/entity/Q41092838

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

@en

type

Item

label

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

@en

prefLabel

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

@en

P1476

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

@en

P2093

Chin-Hsiao Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Repurposing metformin for cancer treatment: current clinical studies

Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis

Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis

LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer

Global cancer statistics, 2012

Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.

Association between diabetes or antidiabetic therapy and lung cancer: A meta-analysis

Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.

Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study.

Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.

P304

41132-41142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17066

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28456789

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

5522244

http://www.w3.org/2001/XMLSchema#string

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

about

P2860

P2860

Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932